Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Teva
Colorcon
Baxter
Deloitte
Merck

Generated: March 18, 2019

DrugPatentWatch Database Preview

Ciprofloxacin hydrochloride; fluocinolone acetonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ciprofloxacin hydrochloride; fluocinolone acetonide and what is the scope of ciprofloxacin hydrochloride; fluocinolone acetonide freedom to operate?

Ciprofloxacin hydrochloride; fluocinolone acetonide is the generic ingredient in one branded drug marketed by Laboratorios Salvat and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Ciprofloxacin hydrochloride; fluocinolone acetonide has sixteen patent family members in thirteen countries.

There are thirty-four drug master file entries for ciprofloxacin hydrochloride; fluocinolone acetonide. One supplier is listed for this compound.

Summary for ciprofloxacin hydrochloride; fluocinolone acetonide
International Patents:16
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 34
Suppliers / Packagers: 1
DailyMed Link:ciprofloxacin hydrochloride; fluocinolone acetonide at DailyMed
Pharmacology for ciprofloxacin hydrochloride; fluocinolone acetonide

US Patents and Regulatory Information for ciprofloxacin hydrochloride; fluocinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Laboratorios Salvat OTOVEL ciprofloxacin hydrochloride; fluocinolone acetonide SOLUTION/DROPS;OTIC 208251-001 Apr 29, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Laboratorios Salvat OTOVEL ciprofloxacin hydrochloride; fluocinolone acetonide SOLUTION/DROPS;OTIC 208251-001 Apr 29, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for ciprofloxacin hydrochloride; fluocinolone acetonide

Country Patent Number Estimated Expiration
Argentina 080368 ➤ Try a Free Trial
Japan 2013521245 ➤ Try a Free Trial
South Korea 20130026430 ➤ Try a Free Trial
Canada 2790652 ➤ Try a Free Trial
Mexico 2012010009 ➤ Try a Free Trial
Denmark 2366408 ➤ Try a Free Trial
Japan 5744922 ➤ Try a Free Trial
Country Patent Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for ciprofloxacin hydrochloride; fluocinolone acetonide

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1429780 13C0012 France ➤ Try a Free Trial PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
1429780 SPC/GB12/058 United Kingdom ➤ Try a Free Trial PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fuji
McKesson
US Department of Justice
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.